VBI Vaccines Inc (VBIV)
0.933
-0.06 (-6.11%)
USD |
NASDAQ |
May 23, 14:31
VBI Vaccines Shareholders Equity (Quarterly): 129.56M for March 31, 2022
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2022 | 129.56M |
December 31, 2021 | 143.88M |
September 30, 2021 | 160.14M |
June 30, 2021 | 168.08M |
March 31, 2021 | 180.01M |
December 31, 2020 | 171.70M |
September 30, 2020 | 165.81M |
June 30, 2020 | 126.61M |
March 31, 2020 | 74.43M |
December 31, 2019 | 88.26M |
September 30, 2019 | 97.22M |
June 30, 2019 | 76.25M |
March 31, 2019 | 86.70M |
December 31, 2018 | 98.13M |
September 30, 2018 | 77.13M |
June 30, 2018 | 89.80M |
March 31, 2018 | 106.46M |
December 31, 2017 | 119.79M |
September 30, 2017 | 62.97M |
June 30, 2017 | 69.36M |
March 31, 2017 | 75.86M |
December 31, 2016 | 83.73M |
September 30, 2016 | 79.50M |
June 30, 2016 | 86.54M |
March 31, 2016 | 10.42M |
Date | Value |
---|---|
December 31, 2015 | 12.19M |
September 30, 2015 | 29.42M |
June 30, 2015 | 79.66M |
March 31, 2015 | 80.95M |
December 31, 2014 | 153.58M |
September 30, 2014 | 154.03M |
June 30, 2014 | 161.77M |
March 31, 2014 | 156.92M |
December 31, 2013 | 164.51M |
September 30, 2013 | 171.45M |
June 30, 2013 | 169.15M |
March 31, 2013 | 175.38M |
December 31, 2012 | 180.00M |
September 30, 2012 | 182.95M |
June 30, 2012 | 179.26M |
March 31, 2012 | 184.57M |
December 31, 2011 | 182.86M |
September 30, 2011 | 182.24M |
June 30, 2011 | 197.93M |
March 31, 2011 | 158.18M |
December 31, 2010 | 16.93M |
September 30, 2010 | 15.08M |
June 30, 2010 | 4.675M |
March 31, 2010 | 4.914M |
December 31, 2009 | 4.605M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
62.97M
Minimum
Sep 2017
180.01M
Maximum
Mar 2021
114.61M
Average
102.30M
Median
Shareholders Equity (Quarterly) Benchmarks
Voyager Therapeutics Inc | 75.93M |
NovaBay Pharmaceuticals Inc | 17.75M |
Palatin Technologies Inc | 28.09M |
iBio Inc | 79.38M |
Synthetic Biologics Inc | 68.03M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 194.01M |
Total Liabilities (Quarterly) | 64.44M |
Debt to Equity Ratio | 0.2279 |
Current Ratio | 3.305 |
Net Debt Paydown Yield | -0.62% |